Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.0068 USD
Change Today 0.00 / 0.00%
Volume 1.0M
BHRT On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 05/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Keith L. March M.D., Ph.D.

Member of Scientific Advisory Board, Bioheart, Inc.
AgeTotal Calculated CompensationThis person is connected to 84 board members in 4 different organizations across 5 different industries.

See Board Relationships
----

Background*

Dr. Keith L. March, M.D., Ph.D serves as a Director of the Indiana Center for Vascular Biology Center. Dr. March served as a Scientific Advisor of Biocardia Inc. Dr. March served as a Consultant of Medtronic ATS Medical, Inc. He served as a Scientific Advisor to numerous pharmaceutical, biotechnology and medical device companies. He serves as the Cryptic Masons Chair in Vascular Biology and Medicine. He made research in the area of the molecular physiology of vascular ...

Read Full Background

Corporate Headquarters*

13794 NW 4th Street
Sunrise, Florida 33325

United States

Phone: 954-835-1500
Fax: 954-845-9976

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD
Indiana University Medical Center
MD
Indiana University Medical Center

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BHRT:US $0.01 USD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Gil Van Bokkelen Ph.D.Co-Founder, Chairman and Chief Executive Officer
Athersys, Inc.
$599.8K
Robin C. Stracey Interim Chief Executive Officer, Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Governance & Nominating Committee
Cesca Therapeutics Inc.
--
Martin M. McGlynn Chief Executive Officer, Director, Chief Executive Officer of Stemcells California Inc, President of Stemcells California Inc and Member of Strategic Transactions Committee
StemCells Inc.
$835.8K
Martin P. Rosendale Chief Executive Officer and Director
Nuo Therapeutics, Inc.
$467.3K
Andrey Semechkin Ph.D.Co-Chairman and Chief Executive Officer
International Stem Cell Corporation
$246.1K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOHEART INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.